Sorafenib in Treating Patients Who Are Undergoing Surgery for Metastatic Kidney Cancer

Clinical trial NCT00126659 · TERMINATED

Trial details

NCT number: NCT00126659
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Clear Cell Renal Cell Carcinoma Recurrent Renal Cell Cancer Stage IV Renal Cell Cancer

Start date: 2006-01-01
Primary completion: 2009-12-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.